SELECT LANGUAGE BELOW

A major genetic study has discovered a new treatment approach for ADHD

A major genetic study has discovered a new treatment approach for ADHD

Attention disorders like ADHD happen when the brain struggles to filter out significant signals from constant background noise. The brain constantly navigates through sights, sounds, and internal thoughts, and effectively concentrating relies on its ability to dismiss distractions while paying attention to what truly matters. Most existing treatments tend to enhance attention by boosting activity in the brain circuits that manage focus, particularly in the prefrontal cortex.

A recent study proposes an alternative approach. Rather than amplifying brain activity, the researchers suggest that reducing baseline activity might help lower mental noise and enhance attention.

A Gene Linked to Calmer Focus

In research published in Nature Neuroscience, scientists reveal that a gene known as Homer1 significantly influences attention by affecting how active or quiet the brain is during rest. Mice with diminished levels of two specific forms of this gene exhibited calmer brain activity and performed better on tasks that demanded focus.

These discoveries could mark the beginning of new treatments aimed at soothing the mind, as opposed to stimulating it. The findings may have broader implications since Homer1 has also been associated with disorders characterized by early sensory processing differences, such as autism and schizophrenia.

“The gene we identified has a remarkable effect on attention and is important for humans,” states Priya Rajasethupathy, head of the Skoler Horbach Family Laboratory of Neural Dynamics and Cognition at Rockefeller.

An Unexpected Genetic Target

Initially, when the research team began looking into the genetics of attention, Homer1 wasn’t an obvious choice. While scientists have recognized the gene’s role in neurotransmission for a long time, many interacting proteins associated with Homer1 have come up in genetic studies about attention disorders, but the gene itself hadn’t stood out as a primary factor before.

To explore further, the researchers examined the genomes of nearly 200 mice from eight distinct parental strains, including some with wild ancestry. This method was meant to mirror the genetic diversity found in human populations and allowed for the emergence of subtle genetic influences.

“It was an enormous undertaking and quite innovative for the field,” Rajasethupathy says, crediting PhD student Zachary Gershon for spearheading the effort.

A Large Genetic Effect on Attention

This extensive genetic analysis unveiled a clear trend. Mice that excelled in attention tasks had significantly lower levels of Homer1 in the prefrontal cortex, a crucial brain region for focus. The gene was situated within a DNA segment that accounted for nearly 20 percent of the variability in attention observed among the mice.

“[That’s] a substantial effect,” Rajasethupathy notes. “Even considering any potential overestimation of this effect, which can happen for various reasons, that’s a striking figure. Typically, finding a gene that influences even 1 percent of a trait is considered lucky.”

Timing Is Critical During Brain Development

Further analyses indicated that not all variations of Homer1 had the same impact. Two specific variants, Homer1a and Ania3, were linked to differences in attention. Mice that did well in attention tasks naturally had reduced levels of these variants in their prefrontal cortex, while other gene forms remained unchanged.

When researchers deliberately lowered Homer1a and Ania3 during a short developmental phase in young mice, the results were notable. The mice became quicker, more precise, and less prone to distractions across several behavioral assessments. Making similar changes in adult mice showed no benefits, suggesting that Homer1‘s impact on attention is confined to a specific early-life window.

How Quieting the Brain Improves Focus

The most surprising insight came from studying how Homer1 affects brain cells. Reducing Homer1 levels in prefrontal cortex neurons led these cells to increase GABA receptors—the calming agents of the nervous system.

This adjustment diminished unnecessary background firing while allowing for strong, concentrated bursts of activity when critical cues appeared. Instead of maintaining constant activity, neurons reserved their firing for the moments that really needed attention, resulting in more precise responses.

“We assumed the more attentive mice would display greater activity in the prefrontal cortex, not less,” Rajasethupathy remarks. “But it does make sense. Attention partly involves filtering out everything else.”

A Calmer Way to Think About Attention

For Gershon, who has ADHD, the findings resonated personally. “It feels like part of my journey,” he shares, “and it’s one of the reasons I was motivated to use genetic mapping to explore attention.”

He was also the first in the lab to observe that reducing Homer1 enhanced focus by minimizing distractions. In his perspective, the results align with everyday experiences. “Deep breathing, mindfulness, meditation—people often say they have better focus after doing these activities,” he mentions.

Rethinking Future Treatments

Current approaches to treating attention disorders mainly boost excitatory signaling in prefrontal brain circuits using stimulant medications. The new findings suggest an alternative route: therapies that enhance attention by calming neural activity instead of intensifying it.

Since Homer1 and its associated proteins are tied to ADHD, schizophrenia, and autism, further research might transform how scientists view various neurodevelopmental conditions.

Upcoming studies from Rajasethupathy’s lab will aim to deepen the genetic understanding of attention, aspiring to create therapies that accurately adjust Homer1 levels.

“There exists a splice site in Homer1 that could be targeted pharmacologically, which might serve as an ideal way to fine-tune brain signal-to-noise levels,” Rajasethupathy suggests. “This presents a concrete opportunity for developing a medication that could offer a similar calming effect as meditation.”

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News